Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Dec 19;22:15330338231218163. doi: 10.1177/15330338231218163

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — Relationship between COLEC12 expression and clinicopathological features and prognosis of gastric cancer (GC) patients. (A) Patients with high COLEC12 expression showed higher rates of more advanced T-stage, pathological stage, and higher histological grade. (B) High COLEC12 expression indicated poor progression-free survival (PFS) and overall survival (OS) in GC patients. (C) Immunohistochemical analysis of COLEC12 expression in GC tissue microarrays (TMA). Representative images are shown at 200 × magnification; Scale bar = 100 µm. (D) The expression of COLEC12 in the GC tissues of different T-stages. STAD, stomach adenocarcinoma; *P < .05; **P < .01; ***P < .001. COLEC12, Collectin subfamily member 12.